MCCPDC Trademark

Trademark Overview

On Friday, March 11, 2022, a trademark application was filed for MCCPDC with the United States Patent and Trademark Office. The USPTO has given the MCCPDC trademark a serial number of 97307522. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, September 12, 2024. This trademark is owned by Mark Cuban Cost Plus Drug Company, PBC. The MCCPDC trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Custom manufacture of drugs, medications, and pharmaceuticals by pharmaceutical compounders
mccpdc

General Information

Serial Number97307522
Word MarkMCCPDC
Filing DateFriday, March 11, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, September 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 31, 2023

Trademark Statements

Goods and ServicesCustom manufacture of drugs, medications, and pharmaceuticals by pharmaceutical compounders
Pseudo MarkMARK CUBAN COST PLUS DRUG COMPANY

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, March 16, 2022
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMark Cuban Cost Plus Drug Company, PBC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLittleton, CO 80123
Party NameMark Cuban Cost Plus Drug Company, PBC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLittleton, CO 80123

Trademark Events

Event DateEvent Description
Tuesday, March 15, 2022NEW APPLICATION ENTERED
Wednesday, March 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 6, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, October 13, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, October 14, 2022ASSIGNED TO LIE
Friday, October 14, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, December 22, 2022ASSIGNED TO EXAMINER
Wednesday, December 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 11, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 31, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 31, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 20, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 20, 2023SOU EXTENSION 1 FILED
Wednesday, September 20, 2023SOU EXTENSION 1 GRANTED
Friday, September 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 15, 2024SOU TEAS EXTENSION RECEIVED
Friday, March 15, 2024SOU EXTENSION 2 FILED
Friday, March 15, 2024SOU EXTENSION 2 GRANTED
Saturday, March 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 12, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 12, 2024SOU EXTENSION 3 FILED
Thursday, September 12, 2024SOU EXTENSION 3 GRANTED

Related Keywords

mccpdc pharmaceutical compounders pharmaceuticals medications manufacture drugs custom